免疫评分可以改善固体瘤患者的预后和治疗管理吗?
Jing-Lun Xu1, Meng-Xiang Yang2, Huan-Rong Lan3
1Department of Dermatology, Jinhua Fifth Hospital, Jinhua, Zhejiang 321000, China.
International immunopharmacology
|September 28, 2023
概括
免疫评分 (ISc) 是通过分析瘤微环境来预测实体瘤的结果的一个有希望的工具. 它显示了指导治疗决策和改善患者管理的潜力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症的诊断 癌症的诊断
背景情况:
- 免疫评分 (ISc) 是一种新兴的基于免疫的评分系统.
- 它评估了瘤微环境 (TME) 中的免疫透物.
- ISc显示了改善固体瘤的预后和治疗管理的潜力.
研究的目的:
- 审查支持免疫评分 (ISc) 预后价值的临床证据.
- 探索ISc在指导固体瘤治疗决策方面的潜力.
- 讨论ISc实施的挑战和未来方向.
主要方法:
- 对Immunoscore (ISc) 实用性的临床证据的审查.
- 与传统遗传病理学相比,ISc的预测能力的分析.
- 在指导辅助疗法和免疫检查点抑制剂 (ICI) 选择中探索ISc.
主要成果:
- ISc显示出优越的预测能力超过传统的病原体参数.
- 在结直肠癌,肺癌,乳腺癌和黑色素瘤中,ISc特别有前途.
- ISc有潜力识别那些将从特定治疗中受益的患者.
结论:
- 免疫评分 (ISc) 是固体瘤预后和治疗管理的宝贵工具.
- 为了将ISc.纳入常规临床,需要进一步的研究和标准化.
- ISc可以帮助个性化治疗策略,包括辅助疗法和ICI选择.
相关概念视频
Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Vaccines
396
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
396


